Allergy Therapeutics (AGY) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Oct 2022 01:27 PM
RNS
Allergy Therapeutics - Result of GM
04 Oct 2022 07:00 AM
RNS
UK manufacturing update
29 Sep 2022 12:00 PM
RNS
Allergy Therapeutics at Investor Meet Company
29 Sep 2022 07:00 AM
RNS
Subscription and Debt Financing
29 Sep 2022 07:00 AM
RNS
Unaudited Preliminary Results 2022
05 Sep 2022 07:00 AM
RNS
Allergy Therapeutics at H.C. Wainwright Conference
02 Sep 2022 04:50 PM
RNS
Total Voting Rights
02 Aug 2022 12:58 PM
RNS
Block Listing Interim Review
15 Jul 2022 07:00 AM
RNS
Trading Update and Notice of Results
01 Jul 2022 07:00 AM
RNS
Allergy Therapeutics at EAACI Congress 2022
26 May 2022 07:00 AM
RNS
Nick Wykeman to step down as CFO
23 May 2022 07:00 AM
RNS
Allergy Therapeutics at H.C. Wainwright Conference
25 Apr 2022 07:00 AM
RNS
Allergy Therapeutics shares data at WAO-BSACI
08 Mar 2022 07:00 AM
RNS
Allergy Therapeutics at Cowen Health Conference
07 Mar 2022 07:00 AM
RNS
Allergy Therapeutics at Investor Meet Company
03 Mar 2022 07:00 AM
RNS
Allergy Therapeutics plc - Interim Results
01 Mar 2022 07:00 AM
RNS
Allergy Therapeutics shares positive new data
24 Feb 2022 04:41 PM
RNS
Second Price Monitoring Extn
24 Feb 2022 04:36 PM
RNS
Price Monitoring Extension
24 Feb 2022 02:06 PM
RNS
Second Price Monitoring Extn
24 Feb 2022 02:01 PM
RNS
Price Monitoring Extension
02 Feb 2022 11:05 AM
RNS
Secures new revolving credit facility
01 Feb 2022 02:16 PM
RNS
Total Voting Rights
26 Jan 2022 07:00 AM
RNS
FDA clearance of IND application for VLP Peanut
24 Jan 2022 01:13 PM
RNS
Holding(s) in Company
13 Jan 2022 07:00 AM
RNS
Half Year Trading Update & Notice of Results
05 Jan 2022 08:47 AM
RNS
Total Voting Rights
25 Nov 2021 09:17 AM
RNS
Allergy Therapeutics: Granting of Awards
23 Nov 2021 12:54 PM
RNS
Result of AGM
11 Nov 2021 07:00 AM
RNS
Director Dealings
27 Oct 2021 07:00 AM
RNS
Cheryl MacDiarmid appointed to Board of Directors
25 Oct 2021 09:00 AM
RNS
Price Monitoring Extension
25 Oct 2021 07:00 AM
RNS
Allergy announces positive G309 results
14 Oct 2021 09:24 AM
RNS
Holding(s) in Company
07 Oct 2021 04:37 PM
RNS
Annual Report and AGM Notification
23 Sep 2021 07:00 AM
RNS
Preliminary Results for Year ended 30 June 2021
16 Sep 2021 07:00 AM
RNS
ImmunoBON voted Most Innovative Product of 2021
13 Sep 2021 07:00 AM
RNS
Secondary endpoints from VLP Peanut 001
09 Sep 2021 07:00 AM
RNS
Allergy to Present at H.C. Wainwright Conference
07 Sep 2021 07:00 AM
RNS
Allergy to host KOL webinar on VLP Peanut
03 Aug 2021 07:00 AM
RNS
Successful primary outcome of VLP Peanut 001
02 Aug 2021 10:57 AM
RNS
Total Voting Rights
14 Jul 2021 07:00 AM
RNS
Trading update for the year ended 30 June 2021
08 Jul 2021 07:00 AM
RNS
AGY to present key scientific findings at EAACI
24 Jun 2021 07:00 AM
RNS
Trading Update
01 Jun 2021 03:36 PM
RNS
Total Voting Rights
10 May 2021 02:06 PM
RNS
Second Price Monitoring Extn
10 May 2021 02:00 PM
RNS
Price Monitoring Extension
06 May 2021 07:00 AM
RNS
Completion of treatment phase in G309 study
30 Apr 2021 05:47 PM
RNS
Total Voting Rights
UK 100

Latest directors dealings